purinergic P1 receptor antagonists

Preferred Label : purinergic P1 receptor antagonists;

MeSH definition : Compounds that bind to and block the stimulation of PURINERGIC P1 RECEPTORS.;

MeSH synonym : P1 purinoceptor antagonists; antagonists, P1 purinoceptor; purinoceptor antagonists, P1; adenosine receptor antagonists; antagonists, adenosine receptor; receptor antagonists, adenosine; Purinergic P1 Receptor Antagonist; Adenosine Receptor Antagonist; Antagonist, Adenosine Receptor; Receptor Antagonist, Adenosine; P1 Purinoceptor Antagonist; Antagonist, P1 Purinoceptor; Purinoceptor Antagonist, P1;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D058915;

UMLS CUI

C2936829;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Adenosine receptor antagonist (disposition) [SNOMED CT concept]
- Substance with adenosine receptor antagonist mechanism of action (substance) [SNOMED CT concept]
Indexing information
- 2-amino-4-phenyl-8-pyrrolidin-1-ylmethylindeno(1,2-d)pyrimidin-5-one [MeSH Supplementary Concept]
- 4-allyl-8-ethyl-7,8-dihydro-2-(3-methoxy-1-methyl-1H-pyrazol-5-yl)-1H-imidazo(2,1-i)purin-5(4H)-one [MeSH Supplementary Concept]
MeSH Descriptor(s) used for indexing
- receptors, purinergic p1 [MeSH Descriptor]
Record concept(s)
- purinergic P1 receptor antagonists [MeSH concept]
See also inter- (CISMeF)
- Product containing adenosine receptor antagonist (product) [SNOMED CT concept]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- (2-amino-4,5,6,7-tetrahydrobenzo(b)thiophen-3-yl)(4-chloronaphthalen-1-yl)methanone [MeSH Supplementary Concept]
- (2-amino-4,5,6,7-tetrahydrobenzo(b)thiophen-3-yl)(4-iodonaphthalen-1-yl)methanone [MeSH Supplementary Concept]
- 1,3-dipropyl-8-(4-sulfophenyl)xanthine [MeSH Supplementary Concept]
- 1-((7-methyl-2-phenylimidazo(1,2-a)(1,3,5)triazin-4-yl)amino)acetone [MeSH Supplementary Concept]
- 1-benzyl-3-propyl-1H,3H-pyrido(2,1-f)purine-2,4-dione [MeSH Supplementary Concept]
- 2,3-diethyl-4,5-dipropyl-6-phenylpyridine-3-thiocarboxylate-5-carboxylate [MeSH Supplementary Concept]
- 2,4-diethyl-1-methyl-3-(ethylsulfanylcarbonyl)-5-ethyloxycarbonyl-6-phenylpyridinium [MeSH Supplementary Concept]
- 3,6-dichloro-2'-isopropyloxy-4'-methylflavone [MeSH Supplementary Concept]
- 4-amino-6-benzylamino-1,2-dihydro-2-phenyl-1,2,4-triazolo(4,3-a)-quinoxalin-1-one [MeSH Supplementary Concept]
- 5-(((4-fluorosulfonylphenyl)amino)carbonyl)amino-8-n-propyl-2-(2-furyl)pyrazolol(4,3-e)1,2,4-triazolo(1,5-c)pyrimidine [MeSH Supplementary Concept]
- 5-(((4-pyridyl)amino)carbonyl)amino-8-methyl-2-(2-furyl)pyrazolo(4,3-e)1,2,4-triazolo(1,5-c)pyrimdiine [MeSH Supplementary Concept]
- 8-(4-sulfophenyl)theophylline [MeSH Supplementary Concept]
- 8-cyclohexylcaffeine [MeSH Supplementary Concept]
- 8-cyclopenta-3-(3-fluoropropyl)-1-propylxanthine [MeSH Supplementary Concept]
- 8-cyclopentyl-1,3-dimethylxanthine [MeSH Supplementary Concept]
- 8-cyclopentyl-3-(3-(4-fluorosulfonylbenzamido)propyl)-1-propylxanthine [MeSH Supplementary Concept]
- 8-dipropyl-8-cyclopentylxanthine [MeSH Supplementary Concept]
- FSPTP pyrimidine [MeSH Supplementary Concept]
- KF 17387 [MeSH Supplementary Concept]
- KF 20274 [MeSH Supplementary Concept]
- KFM 19 [MeSH Supplementary Concept]
- MRE 3008-F20 [MeSH Supplementary Concept]
- MRS 1097 [MeSH Supplementary Concept]
- MRS 1204 [MeSH Supplementary Concept]
- MRS 1595 [MeSH Supplementary Concept]
- MRS 1740 [MeSH Supplementary Concept]
- MRS 1741 [MeSH Supplementary Concept]
- N-(3-(2-pyridinyl)isoquinolin-1-yl)benzamidine [MeSH Supplementary Concept]
- VUF 5472 [MeSH Supplementary Concept]
- VUF 8504 [MeSH Supplementary Concept]
- WRC 0571 [MeSH Supplementary Concept]
- alpha-((4-(methylamino)-1-phenylpyrazolo(3,4-d)pyrimidin-6-yl)thio)hexanamide [MeSH Supplementary Concept]
- alpha-((4-amino-1-phenylpyrazolo(3,4-d)pyrimidin-6-yl)thio)hexanamide [MeSH Supplementary Concept]
- aminophylline [MeSH Descriptor]
- caffeine [MeSH Descriptor]
- propyl 1-ethyl-8-oxo-3-phenyl-5,6,7,8-tetrahydro-7-thiaisoquinoline-4-carboxylate [MeSH Supplementary Concept]
- theophylline [MeSH Descriptor]
UMLS correspondences (same concept)
- Product containing adenosine receptor antagonist (product) [SNOMED CT concept]
- Substance with adenosine receptor antagonist mechanism of action (substance) [SNOMED CT concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients